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Introduction
Breast reconstruction (BR) not only brings shape to a 
breast it also restores a woman’s identity, attractiveness 
and sexual desirability, and hence affects their quality of 
life (1). Following the procedure, patients experience 
several complications; nonetheless, rates of breast cancer 
recurrence appear not to be a direct consequence of 
breast reconstruction. The multivariate mechanisms that 
would essentially elucidate recurrence in vitro seem not 
to translate clinically (2). Thus, breast cancer patients, 
who have undergone a mastectomy, should have a BR 
recommendation for maximal management of patients 
(3). 
There are, however, predictors that affect the rates 
of BR postmastectomy (1,4). The reasons stated for 
getting a BR are physician-associated, patient-associated, 
and healthcare financing (4,5). Data is limited on post-
mastectomy breast reconstruction (PMBR) from the 
African countries. In developing countries, the procedure 
is unpopular in the full rehabilitation of the patient. 
Further accreditation may arise from few plastic surgeons 
and heavy workload, and not many patients know about 
their rehabilitation options postmastectomy (1).
In Kenya, no data has been published describing the 
limitations and rates of breast reconstruction following 
mastectomy. In this study, we aimed to determine the 
predictors for breast reconstruction.
Materials and Methods
This retrospective hospital-based, case-control study 
made use of the resources of the Kenyatta National 
Hospital database. The population for this study 
targeted opt-in female patients 18 years and above and 
postmastectomy patients diagnosed with breast cancer 
between 2014 to 2018. The cases and controls matched 
because they underwent a mastectomy procedure; the 
cases had breast reconstruction while the controls did 
not. The primary outcome was breast reconstruction 
defined by these codes for implant-based reconstruction 
(IBR) and autologous reconstruction (AR).
We investigated the following patient predictor variables: 
age, ethnicity, medical comorbidities, insurance status, 
income, marital status, religion, level of education, 
postoperative need for radiotherapy and chemotherapy, 
and contralateral prophylactic mastectomy. We entered 
all information in a computer and analysed it using 
SPSS version 25 (Inc, Chicago, IL, USA) for Windows 
and MacOS. We obtained consent for the study from 
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Kenyatta National Hospital University of Nairobi Ethics 
and Research Committee (UP600/08/2018).
Results
Sample characteristics
Mastectomy patients. The mean age of patients at the 
time of mastectomy was 46.79 (20.71–72.87) years, 
and the modal age 40 years. Most patients (58.9%) were 
married, 26% were single, 8% widowed, 7% separated, 
and 1% divorced. Only 2.74% of patients had a bilateral 
mastectomy. In our study, 98.2% of these mastectomy 
patients were Christians, and only 1.8% Muslims. 
Most mastectomy patients (84.4%) were Bantus, 
14.2% Nilotes, and 1.4% Cushites. The highest level 
of education for most patients (43.8%) was secondary 
education, next was primary (30.1%), tertiary (19.2%) 
and 6.8% had no formal education. We looked at the 
10-year survival rate of the patients using the Charlson 
comorbidity index. Most patients (48.4%) had a 90% 
probability of surviving (Fig. 1).
Almost 90% of patients had insurance: most (96.9%) 
could afford paying premiums for the National Health 
Insurance Fund (NHIF). Notably, most of the patients 
who underwent mastectomy (68%) had another mode 
of payment besides the insurance.
The modal breast size was 40D (27.9%). Modified 
radical mastectomy (MRM) was the most common 
at 72.6%. Most patients needed further treatment: 
55.3% needed radiotherapy, while 89% had to undergo 
chemotherapy. A few patients (2.7%) underwent 
contralateral prophylactic mastectomy. We included all 
mastectomy patients in the study.
Breast reconstruction patients. The cases included nine 
female patients with a mean age of 34.33 (16.00–52.66) 
years; modal age was 35, and all were Christians. Eight 
of these patients were married and Bantu. The highest 
level of education was tertiary, for seven patients; two 
patients had reached secondary school. For physical 
characteristics, the modal breast size was 40D (three 
patients). Using the Charlson comorbidity index, 
seven patients had a 90% probability of surviving, one 
a probability of 77% and one a 0% probability. Eight 
patients had insurance cover: six patients could afford 
the NHIF and two had private insurance. For the breast 
reconstruction patients, six patients had no other mode 
of payment other than insurance cover, one patient was 
financed by the community, and one paid out of pocket.
Trend in breast reconstruction. The KNH database 
yielded data for 312 women with codes for mastectomy. 
In this group, nine women had breast reconstruction 
after mastectomy, for an overall reconstruction rate 
of 2.88%. The rate increased annually over the study 
period, reaching a peak of 10.81% in 2017 and then 
sharply dropping to 1.41% in 2018, coinciding with an 
increase in the number of mastectomies from 37 in 2017 
to 71 in 2018. The average number of mastectomies 
per year was 57. Figure 2 shows the five-year trend 
using a polynomial trend line, which is used when data 
fluctuates in linear regression (R2=1, the perfect fit). 
All breast reconstructions were autologous (latissimus 
flap). Figure 3 shows the pattern of immediate versus 
delayed breast reconstruction and includes polynomial 
trendlines to demonstrate a progressive increase in 
immediate breast reconstructions over time compared 
with a predicted decline delayed breast reconstruction 
(R2=1, the perfect fit).
		
Figure	2:	Postmastectomy	breast	reconstruction	rate	by	fiscal	year	of	mastectomy.	
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Figure 1. The Charlson comorbidity index for mastectomy 
patients
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Figure 2. Postmastectomy breast reconstruction rate by fiscal 
year of mastectomy.
Figure 3. Number of immediate and delayed breast 
reconstructions by fiscal year of mastectomy
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Binary logistic regression. In the binary logistic regression, 
breast reconstruction was the primary dependent 
variable and it had a dichotomous response (No or 
Yes). The best-fitted model showed that insurance cover 
and age (Table 1) accounted for 52.3% of the variance 
of having undergone breast reconstruction. Hosmer- 
Lemeshow goodness-of-fit test was greater than 0.05 (at 
0.972), showing that the fitted model had a good fit. 
Age. Age had a negative beta coefficient of –0.102, 
meaning that undergoing breast reconstruction becomes 
less likely as the predictor age increases. We coded age 
as a binary variable: below 50 years and 50 and above 
years. WHO defines old age arbitrarily in Africa as 50 
years, therefore in our study we used 50 years as the 
lower age threshold for considering older patients, and 
anyone below 50 was considered “young” (6). Among 
the young women, the modal cohort was 26 to 35 years 
of age at 44% (Fig. 4).
Insurance. Insurance coverage had a negative beta 
coefficient of –4.836, indicative of a negative association. 
Therefore, breast reconstruction following mastectomy 
becomes less likely for patients whose insurance does 
not cover breast reconstruction following mastectomy 
(Table 1). 
Table 1. Binary logistic regression analysis of factors affecting 
incidence of post-mastectomy breast reconstruction
Factor Odds ratio (95% CI) p value 
Age 0.175 (0.004–0.345) <0.001
Insurance coverage 0.008 (0.001–0.061) <0.001
Discussion
From our hospital-based study, 2.88% of postmastectomy 
patients underwent BR in five years. This rate is 
substantially lower than in Canadian hospital-based 
studies on BR that range from 3.8% to 21%. The same 
holds for tertiary care centers in the United States, 
whereby the rates of BR go up to 42% (4,7). In Asia, a 
similar study showed a rate of 24.3% while in China the 
rate remains stable at 3.5–4.5% over the past 15 years 
(8,9). Our study focused on a tertiary public hospital; a 
comparative study in a private hospital in Kenya has yet 
to be done.
We demonstrate that the proportion of unilateral 
mastectomy is high, whereas bilateral mastectomy 
remains low. This proportional difference is unique as 
trends show the rate of bilateral mastectomy is increasing, 
whereas unilateral mastectomy rates are decreasing (10).
Our five-year trend shows a gradual increase in the rate of 
BR as in the case in Canada, USA, China, and Singapore 
(7–9). This finding may suggest a rise in the awareness 
of BR. With time, more women have increased access to 
information about BR from the internet.
All breast reconstructions were autologous (latissimus 
flap). This trend is unique to other countries where 
both implant and autologous based surgery utility is 
present. The overall trend is an increase in implant-
based BR since most patients are opting for immediate 
breast reconstruction. We state that there is a progressive 
increase in immediate breast reconstructions over time 
compared to a predicted decline delayed BR in our 
tertiary center similar to other hospital-based studies 
(7–9,11). Further research into the determinants of 
timing of the BR needs to be explored, as our study 
design limited the ability to capture the influences of the 
trend at our hospital.
Age and insurance coverage of the patient were the only 
significant factors affecting BR in our setup. Age appears 
to be a persistent factor that affects the likelihood of 
undergoing BR in this and other studies. Younger 
patients are more likely to have the procedure done. 
Young patients are less likely to undergo autologous 
reconstruction due to more scar formation at the donor 
site. Patients older than fifty have more complications; 
however, reconstruction is not a contraindication in this 
age group (4,5,7).
Insurance coverage and higher socioeconomic status of 
the community likely facilitate access to BR, as seen in 
our set up (5,12). Yang et al. stated that the possibility 
that patients with non-private health insurance are 
more likely to undertake the delayed BR; in the USA, 
insurance status is strongly associated with receipt of 
immediate BR especially for those with privately bought 
insurance (13). The NHIF covers all surgical procedures 
of therapeutic and preventive value (14). Surgeons do 
not recommend palliative reconstructive surgery as 
gichuru et al.
Figure 4. The rate of breast reconstruction postmastectomy, 
by patient age.
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part of the management of breast cancer patients (3). 
Moreover, there is no documentation of whether NHIF 
covers BR as a cosmetic or a therapeutic procedure. 
Income did not appear as a significant factor in BR in our 
patients. Our finding contradicts the expected as several 
studies predict household income as an influencer of the 
rate of PMBR. In a non-universal health care system, 
women with higher income background were more 
likely to have had PMBR (12,15).  
We found no association between the breast size of a 
patient before mastectomy and the likelihood of getting 
breast reconstruction. The role of preoperative breast 
size in choosing the aptest BR option would have led 
to the conclusion that there would be an association 
(16,17).
This study found no association between the breast size 
of a patient before mastectomy and the likelihood of 
getting breast reconstruction. The role of preoperative 
breast size in choosing the most suitable BR option 
would have led to the conclusion that there would be an 
association (16,17).
Based on our study, the frequency of breast cancer from 
highest to lowest among the black Kenyan tribes is Bantus, 
Nilotes, and Cushites (18). The ethnic background of 
the patient affects the presentation and time of diagnosis 
of disease. Furthermore, ethnicity tended to determine 
the procedure performed. African American women had 
increased rates of bilateral implant-based reconstruction 
while unilateral flap-based reconstructions rates were 
common among Hispanic patients (19). In our study, 
we established no association between the ethnic group 
and BR despite most of our study population being 
Bantu women.
Majority of our breast reconstructed patients have 
a tertiary education. Higher levels of educations are 
associated with an increased ability to comprehend the 
procedure use and outcomes preoperatively as offered by 
the involved surgical stakeholders. This comprehension 
has been shown to lead to increased odds of undergoing 
BR (12,20). However, we did not find any association in 
our current study.
In a review of literature, researchers include marital 
status in the analysis of hinderances of BR (12). 
However, other studies have shown that marital status 
is not an explicit predictor for PMBR (15,21). The later 
was replicated in our study.
We found no association between the comorbidities 
and BR with the aid of the Charlson comorbidity index 
(CCI). In a study looking at the relationship between 
comorbidities and quality of life, the authors established 
that comorbidities did not influence the choice of 
surgery with or without BR (22). In terms of shorter 
overall survival, prognostic factors such as lymph node 
metastasis (the most significant), the grade of disease, 
size of tumor and multifocality of the disease have yet to 
be correlated (23). 
Further therapy is a hindrance to PMBR where 
radiotherapy is associated with AR (4,24). In our 
hospital, we found no associations between the need for 
chemotherapy and radiotherapy as negative predictors 
to PMBR. 
Conclusion 
In this hospital-based study, the rate of post-mastectomy 
breast reconstruction is low in the tertiary referral 
health center in Kenya despite the procedure being an 
essential component of breast cancer care. Efforst must 
be increased to enhance awareness among surgical 
stakeholders and the general population on the surgery. 
Age and insurance coverage are predictors for breast 
reconstruction. 
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